Cargando…
Everolimus and intensive behavioral therapy in an adolescent with tuberous sclerosis complex and severe behavior()()()
BACKGROUND: Self-injury and aggression have been reported in individuals with TSC (tuberous sclerosis complex), yet few data exist about treatment. Everolimus, an mTOR inhibitor, has been FDA-approved for subependymal giant cell astrocytomas (SEGAs) and renal angiomyolipomas in TSC. However, clinica...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150649/ https://www.ncbi.nlm.nih.gov/pubmed/25667844 http://dx.doi.org/10.1016/j.ebcr.2013.06.004 |